Age and Sex Patterns of Hepatitis B and C Seropositivity and Coinfection Among Gastroenterology Outpatients in South Punjab, Pakistan: A Comparative Cross-Sectional Study

Authors

DOI:

https://doi.org/10.65761/pjcr.2026.315

Keywords:

Hepatitis B; Hepatitis C; Seropositivity; Coinfection; Gastroenterology outpatients; Pakistan; Age and sex patterns

Abstract

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the major drivers of liver disease in Pakistan; however, age and sex patterns of seropositivity and coinfection among gastroenterology outpatients in South Punjab are not known.

Objective: To compare age and sex distribution of patients positive for hepatitis B surface antigen (HBsAg) only, antibody to HCV (anti-HCV) only, or both (serological coinfection).

Methods: This comparative cross-sectional study was conducted in the Department of Gastroenterology, Nishtar Medical University and Hospital, Multan from September 2025 to February 2026, involving 717 consecutive symptomatic patients who were positive for HBsAg and/or anti-HCV on third-generation enzyme-linked immunosorbent assay (ELISA) without testing for HCV RNA and HBV DNA. Chi-square, Fisher’s exact and trend tests and unadjusted compositional odds ratios (ORs) were used for analyses. Results refer to composition, not prevalence, as only seropositive patients were included.

Results: There were 543 anti-HCV-only (75.7%; 95% confidence interval [CI] 72.5–78.7), 154 HBsAg-only (21.5%; 18.6–24.6) and 20 with serological coinfection (2.8%; 1.7–4.3). Pattern differed by sex (p = 4.2 × 10⁻⁵) and age (p = 7.1 × 10⁻⁵). Women had higher odds of anti-HCV-only (83.2% vs 68.8%; OR 2.24, 95% CI 1.57–3.21) and men of HBsAg-only (27.7% vs 14.8%; OR 2.21, 1.52–3.21). The anti-HCV-only share increased and the HBsAg-only share decreased across age groups (both trend p < 0.001). Coinfection did not differ by sex (3.5% vs 2.0%; p = 0.26) or age (p = 0.36).

Conclusion: Anti-HCV positivity was more common than HBsAg-only positivity, especially among women and older patients, while HBsAg-only positivity was more common among men and younger adults. These patterns can inform targeted testing and awareness by age and sex, with dual-marker testing and HCV RNA confirmation.

References

1. World Health Organization. Global hepatitis report 2026. Geneva: World Health Organization; 2026. Available from: https://www.who.int/publications/i/item/9789240122383

2. World Health Organization. Hepatitis B [Internet]. Fact sheet. Geneva: World Health Organization; [cited 2026 Mar 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

3. World Health Organization. Hepatitis C [Internet]. Fact sheet. Geneva: World Health Organization; [cited 2026 Mar 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

4. Thomas DL. Global elimination of chronic hepatitis. N Engl J Med. 2019;380(21):2041-50. doi:10.1056/NEJMra1810477

5. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55. doi:10.1016/S0140-6736(15)61412-X

6. Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161-76. doi:10.1016/S2468-1253(16)30181-9

7. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HUR. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J. 2010;16(Suppl): S15-23. doi: 10.26719/2010.16.Supp.15

8. Qureshi H, Alam E, Dharejo Z, Mahmood H. Prevalence of hepatitis and HIV in Pakistan. East Mediterr Health J. 2024;30(10):689-97. doi:10.26719/2024.30.10.689

9. Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect. 1997;119(3):349-56. doi:10.1017/S0950268897007899

10. Butt AS. Epidemiology of viral hepatitis and liver diseases in Pakistan. Euroasian J Hepatogastroenterol. 2015;5(1):43-8. doi:10.5005/jp-journals-10018-1129

11. Umer M, Iqbal M. Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World J Gastroenterol. 2016;22(4):1684-700. doi:10.3748/wjg. v22.i4.1684

12. Ali M, Idrees M, Ali L, Hussain A, Ur Rehman I, Saleem S, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011; 8:102. doi:10.1186/1743-422X-8-102

13. Khan A, Afzal S, Yaqoob A, Fatima R, Ul Haq M, Junaid K, et al. Epidemiology of viral hepatitis B and C in Punjab, Pakistan: a multicenter cross-sectional study, 2017-18. F1000Res. 2019; 8:2065. doi:10.12688/f1000research.20174.1

14. Raziq K, Shah SQA, Tariq M, Badshah S, Riaz U, Ibáñez-Arancibia E, et al. Prevalence and risk factors of hepatitis B and C in Bahawalpur: a hospital-based study. Braz J Biol. 2025;85: e288357. doi:10.1590/1519-6984.288357

15. Konstantinou D, Deutsch M. The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viral interactions and management. Ann Gastroenterol. 2015;28(2):221-8.

16. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer. 1997;76(7):968-74. doi:10.1038/bjc.1997.493

17. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998;75(3):347-54.

18. Zampino R, Pisaturo MA, Cirillo G, Marrone A, Macera M, Rinaldi L, et al. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration. Ann Hepatol. 2015;14(1):75-82.

19. Awadh AA, Alharthi AA, Alghamdi BA, Alghamdi ST, Baqays MK, Binrabaa IS, et al. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis. J Glob Infect Dis. 2024;16(4):127-34. doi: 10.4103/jgid.jgid_211_23

20. Khan J, Shafiq M, Mushtaq S, Ayaz S, Ullah R, AbdEl-Salam NM, et al. Seropositivity and coinfection of hepatitis B and C among patients seeking hospital care in Islamabad, Pakistan. Biomed Res Int. 2014; 2014:516859. doi:10.1155/2014/516859

21. Patoli BB, Patoli AA, Balani NK, Korejo AA. Molecular surveillance of HCV mono-infection and HCV-HBV co-infection in symptomatic population at Hyderabad, Pakistan. Afr Health Sci. 2018;18(3):531-8. doi:10.4314/has. v18i3.9

22. Riaz MN, Faheem M, Anwar MA, Raheel U, Badshah Y, Akhtar H, et al. PCR-based molecular diagnosis of hepatitis virus (HBV and HDV) in HCV infected patients and their biochemical study. J Pathog. 2016; 2016:3219793. doi:10.1155/2016/3219793

23. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. doi:10.1016/S0140-6736(07)61602-X

24. Zafar A, Khan E, Khan MS, Moiz B, Jafri W. Changing trends of hepatitis B seromarkers amongst Pakistani population: a laboratory-based review. J Pak Med Assoc. 2013;63(7):826-30.

25. Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults — United States, 2020. MMWR Recomm Rep. 2020;69(2):1-17. doi:10.15585/mmwr. rr6902a1

26. Bukhtiari N, Hussain T, Iqbal M, Malik AM, Qureshi AH, Hussain A. Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. J Pak Med Assoc. 2003;53(4):136-40.

27. Iqbal S, Qureshi Z, Mudasir HM, Khan A, Sohail A, Ahmad J, et al. Prevalence and risk factors of hepatocellular carcinoma in patients co-infected with hepatitis B virus (HBV) and hepatitis C virus (HCV): a cross-sectional retrospective study. Cureus. 2025;17(6): e85985. doi:10.7759/cureus.85985

28. Kew MC, Yu MC, Kedda MA, Coppin A, Sarkin A, Hodkinson J. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology. 1997;112(1):184-7. doi:10.1016/s0016-5085(97)70233-6

29. Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnù L, Belussi F, et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol. 1995;22(1 Suppl):38-41.

30. Bellecave P, Gouttenoire J, Gajer M, Brass V, Koutsoudakis G, Blum HE, et al. Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference. Hepatology. 2009;50(1):46-55. doi:10.1002/hep.22951

31. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol. 2003;39(6):1036-41. doi:10.1016/S0168-8278(03)00470-7

32. Perumalswami PV, Bini EJ. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coinfection. Minerva Gastroenterol Dietol. 2006;52(2):145-55.

33. Abbas M, Abbas Z, Sharif MY. Community-based double reflex screening reveals widespread hepatitis D viremia among hepatitis B surface antigen carriers in Pakistan. Cureus. 2025;17(6): e85200. doi:10.7759/cureus.85200

Downloads

Published

2026-08-30

How to Cite

1.
Khan H, Muhammad Ilyas, Khan Jadoon T, Jahangir A. Age and Sex Patterns of Hepatitis B and C Seropositivity and Coinfection Among Gastroenterology Outpatients in South Punjab, Pakistan: A Comparative Cross-Sectional Study. Pak J Clin Res [Internet]. 2026 Aug. 30 [cited 2026 Nov. 20];3(8):88-94. Available from: https://pjcr.org/index.php/PJCR/article/view/315

Similar Articles

61-67 of 67

You may also start an advanced similarity search for this article.